Drug Information
Drug Generic Name | NALOXONE HYDROCHLORIDE |
Drug Class | ANTAGONISTS FOR CENTRAL AND RESPIRATORY DEPRESSION |
Chapter | Anesthesia |
Indications reversal of opioid-induced respiratory depression; reversal of neonatal respiratory depression resulting from opioid administration to mother during labour; overdosage with opioids. Cautions: cardiovascular disease or those receiving cardiotoxic drugs (serious adverse cardiovascular effects reported); physical dependence on opioids (precipitates withdrawal); pain, has short duration of action (repeated doses or infusion may be necessary to reverse effects of opioids with longer duration of action); In postoperative use, the dose should be titrated for each patient in order to obtain sufficient respiratory response. Side Effects: hypotension, hypertension, ventricular tachycardia and fibrillation, cardiac arrest; hyperventilation, dyspnea, pulmonary oedema; less commonly agitation, excitement, paraesthesia. Dose: by IV injection, 100-200 mcg (1.5-3mcg/kg). Adjusted according to the response, then 100 mcg every 2 minutes. Neonates, by SC or IM or IV injection, 10 mcg/kg repeated every 2 minutes or 200 mcg (60 mcg/kg) by IM injection as a single dose. |
|
Brand Name |
|